Fate Therapeutics (FATE) Quick Ratio: History & Chart

Fate Therapeutics, Inc.(FATE)

Biotechnology · San Diego, CA

$2.29-0.14 (-5.76%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia (AML), B-cell lymphoma, and advanced solid tumors; FT596 for B-cell lymphoma and chronic lymphocytic leukemia; FT538, addressing AML and multiple myeloma; FT576, also focused on multiple myeloma; FT819, aimed at both hematologic malignancies and solid tumors; FT536, another program for solid tumors; and FT500, intended for advanced solid tumors. The company also actively engages in strategic collaborations to advance its research and development. It holds an agreement with Ono Pharmaceutical Co. Ltd. for the joint development and commercialization of two novel, "off-the-shelf" iPSC-derived CAR T-cell therapies. Furthermore, Fate Therapeutics maintains a research collaboration and licensing deal with Juno Therapeutics, Inc., focusing on identifying small molecule modulators that can enhance the therapeutic efficacy of genetically engineered T-cell immunotherapies. A separate collaboration and option agreement exists with Janssen Biotech, Inc. Established in 2007, Fate Therapeutics, Inc. is based in San Diego, California.

San Diego, CA

161 employees

www.fatetherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Bahram Valamehr

View full financials

FATE Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

4.85

QUICK RATIO (ACID-TEST) AVG TTM

6.48

QUICK RATIO (ACID-TEST) AVG 3Y

8.01

QUICK RATIO (ACID-TEST) AVG 5Y

7.42

QUICK RATIO (ACID-TEST) AVG 10Y

7.31

QUICK RATIO (ACID-TEST) AVG 15Y

7.11

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

-25.18%

CURRENT VS 3Y AVG

-39.52%

CURRENT VS 5Y AVG

-34.72%

CURRENT VS 10Y AVG

-33.66%

CURRENT VS 15Y AVG

-31.82%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

+44.67%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Fate Therapeutics, Inc. (FATE)	$266.92M	4.85	6.48	8.01	7.42
SAB Biotherapeutics, Inc. (SABS)vs ›	$266.59M	9.22	6.22	4.84	4.06
EyePoint Pharmaceuticals, Inc. (EYPT)vs ›	$265.78M	4.46	8.30	6.73	6.78
Scribe Therapeutics Inc. (SCTX)vs ›	$264.25M	N/A	N/A	N/A	N/A
Rocket Pharmaceuticals, Inc. (RCKT)vs ›	$270.80M	9.24	7.84	8.19	10.90
TriSalus Life Sciences, Inc. (TLSI)vs ›	$262.92M	4.97	2.08	1.48	1.89
Vanda Pharmaceuticals Inc. (VNDA)vs ›	$271.81M	1.60	3.38	4.33	4.99
Inhibikase Therapeutics, Inc. (IKT)vs ›	$261.43M	15.82	24.04	14.70	12.06
X4 Pharmaceuticals, Inc. (XFOR)vs ›	$261.27M	11.02	6.66	6.10	6.28
OraSure Technologies, Inc. (OSUR)vs ›	$259.56M	7.68	7.37	6.66	5.96

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Fate Therapeutics, Inc. (FATE)

$266.92M

4.85

6.48

8.01

7.42

SAB Biotherapeutics, Inc. (SABS)vs ›

$266.59M

9.22

6.22

4.84

4.06

EyePoint Pharmaceuticals, Inc. (EYPT)vs ›

$265.78M

4.46

8.30

6.73

6.78

Scribe Therapeutics Inc. (SCTX)vs ›

$264.25M

N/A

Rocket Pharmaceuticals, Inc. (RCKT)vs ›

$270.80M

9.24

7.84

8.19

10.90

TriSalus Life Sciences, Inc. (TLSI)vs ›

$262.92M

4.97

2.08

1.48

1.89

Vanda Pharmaceuticals Inc. (VNDA)vs ›

$271.81M

1.60

3.38

4.33

4.99

Inhibikase Therapeutics, Inc. (IKT)vs ›

$261.43M

15.82

24.04

14.70

12.06

X4 Pharmaceuticals, Inc. (XFOR)vs ›

$261.27M

11.02

6.66

6.10

6.28

OraSure Technologies, Inc. (OSUR)vs ›

$259.56M

7.68

7.37

6.66

5.96

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The quick ratio (acid-test) for FATE stock is 4.85.

Is Fate Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 4.85 is 35% below its 5-year average of 7.42, near the low end of its 5-year range (4.40–9.18).

What is the TTM average quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The TTM average quick ratio (acid-test) for FATE stock is 6.48.

What is the 3Y average quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The 3Y average quick ratio (acid-test) for FATE stock is 8.01.

What is the 5Y average quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The 5Y average quick ratio (acid-test) for FATE stock is 7.42.

What is the 10Y average quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The 10Y average quick ratio (acid-test) for FATE stock is 7.31.

What is the 15Y average quick ratio (acid-test) for Fate Therapeutics, Inc. (FATE)?

The 15Y average quick ratio (acid-test) for FATE stock is 7.11.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	4.85
2026-03-31	5.85
2025-12-31	5.79
2025-09-30	7.87
2025-06-30	8.04
2025-03-31	8.81
2024-12-31	7.58
2024-09-30	8.29
2024-06-30	9.18
2024-03-31	8.69
2023-12-31	8.48
2023-09-30	8.81
2023-06-30	8.78
2023-03-31	9.00
2022-12-31	4.40
2022-09-30	5.15
2022-06-30	6.55
2022-03-31	7.69
2021-12-31	7.79
2021-09-30	7.55
2021-06-30	6.75
2021-03-31	8.50
2020-12-31	5.78
2020-09-30	9.17
2020-06-30	11.92
2020-03-31	8.36
2019-12-31	8.17
2019-09-30	7.57
2019-06-30	5.67
2019-03-31	6.40
2018-12-31	7.53
2018-09-30	9.44
2018-06-30	4.92
2018-03-31	7.20
2017-12-31	9.29
2017-09-30	7.21
2017-06-30	8.92
2017-03-31	4.94
2016-12-31	6.14
2016-09-30	3.23
2016-06-30	3.29
2016-03-31	4.07
2015-12-31	4.88
2015-09-30	5.89
2015-06-30	7.21
2015-03-31	6.67
2014-12-31	10.89
2014-09-30	11.66
2014-06-30	11.08
2014-03-31	11.08
2013-12-31	11.88
2013-09-30	2.04
2013-06-30	0.75
2013-03-31	1.29
2012-12-31	2.02
2012-09-30	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

4.85

2026-03-31

5.85

2025-12-31

5.79

2025-09-30

7.87

2025-06-30

8.04

2025-03-31

8.81

2024-12-31

7.58

2024-09-30

8.29

2024-06-30

9.18

2024-03-31

8.69

2023-12-31

8.48

2023-09-30

8.81

2023-06-30

8.78

2023-03-31

9.00

2022-12-31

4.40

2022-09-30

5.15

2022-06-30

6.55

2022-03-31

7.69

2021-12-31

7.79

2021-09-30

7.55

2021-06-30

6.75

2021-03-31

8.50

2020-12-31

5.78

2020-09-30

9.17

2020-06-30

11.92

2020-03-31

8.36

2019-12-31

8.17

2019-09-30

7.57

2019-06-30

5.67

2019-03-31

6.40

2018-12-31

7.53

2018-09-30

9.44

2018-06-30

4.92

2018-03-31

7.20

2017-12-31

9.29

2017-09-30

7.21

2017-06-30

8.92

2017-03-31

4.94

2016-12-31

6.14

2016-09-30

3.23

2016-06-30

3.29

2016-03-31

4.07

2015-12-31

4.88

2015-09-30

5.89

2015-06-30

7.21

2015-03-31

6.67

2014-12-31

10.89

2014-09-30

11.66

2014-06-30

11.08

2014-03-31

11.08

2013-12-31

11.88

2013-09-30

2.04

2013-06-30

0.75

2013-03-31

1.29

2012-12-31

2.02

2012-09-30

0.00

Quick Ratio (Acid-Test): 4.85

FATE Quick Ratio

FATE Average Quick Ratio (Acid-Test) Chart

FATE Current vs Average Quick Ratio (Acid-Test) Chart

FATE Quick Ratio (Acid-Test) Metrics

FATE Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

FATE Quick Ratio (Acid-Test) History

Related Metrics